Loading clinical trials...
Loading clinical trials...
Physicians tend to always use the lowest dose of statins to initiate therapy even in subjects who require large reductions in cholesterol. The study evaluates if selecting the starting dose based on b...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT07590193 · Diabetes Mellitus, Type 2
NCT00009243 · Brain Disease, Ischemic Attack, Transient, and more
NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more
NCT05644522 · Cerebrovascular Accident, Post-polio Syndrome, and more
NCT02861781 · Obesity, Insulin Resistance, and more
Pfizer Investigational Site
Mississauga, Ontario
Pfizer Investigational Site
Calgary, Alberta
Pfizer Investigational Site
Edmonton, Alberta
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions